Log In Sign Up Premium
  • Markets
    • News
    • Tech
    • Market Movers
    • Futures Forex
    • Macroeconomic Predictions
    • Options
  • Insider Trading
    • Main
    • Education Center
    • Stock Screener
    • Insider Purchases
    • Insider Sales
    • Browse Companies
    • Latest 13D & 13G Filings
  • Hedge Funds
    • Main
    • Education Center
    • Browse Hedge Funds
    • Best Performing
    • Worst Performing
    • Other Institutional Investors
  • Retirement
    • ETF Trading
    • Commodities
    • Gold
    • Dividend Stocks
  • Opinion
    • Main
    • Hedge Fund Analysis
    • Stock Analysis
    • We Disagree
    • Lists
    • Authors
  • Premium
    • Newsletters
    • My Subscriptions
    • Premium Readership
  • Log In
  • Sign Up
Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for Sorry, no results has been found matching your query.

Posts Tagged ‘NASDAQ:ACOR’

Hedge Funds Are Buying Acorda Therapeutics Inc (ACOR) Again

The Insider Monkey team has completed processing the quarterly 13F filings for the March quarter submitted by the hedge funds and other money managers included in our extensive...

Keep Reading →

June 18 - Hedge Funds, News - Comments

Is ACOR A Good Stock To Buy Now?

At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We...

Keep Reading →

December 7 - Hedge Funds, News - Comments

Do Hedge Funds Love Acorda Therapeutics Inc (ACOR)?

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies.

Keep Reading →

July 8 - Hedge Funds, News - Comments

Hedge Fund and Insider Trading News: Bill Ackman, Marshall Wace, Greenlight Capital, Becton Dickinson and Co (BDX), On Track Innovations Ltd (OTIVF), and More

COPENHAGEN (Reuters) - Hedge fund Marshall Wace is betting on Danske Bank (DANSKE.CO) shares falling after taking a short position in the Danish lender of 0.5% of issued shares...

Keep Reading →

January 3 - Hedge Funds, Insider Trading - Comments

Hedge Funds Are Getting Burned By Acorda Therapeutics Inc (ACOR)

After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...

Keep Reading →

December 12 - Hedge Funds, News - Comments

Were Hedge Funds Right About Dumping Acorda Therapeutics Inc (ACOR)?

We are still in an overall bull market and many stocks that smart money investors were piling into surged through October 17th.

Keep Reading →

November 6 - Hedge Funds, News - Comments

Here’s What Hedge Funds Think About Acorda Therapeutics Inc (ACOR)

"The global economic environment is very favorable for investors. Economies are generally strong, but not too strong.

Keep Reading →

June 20 - Hedge Funds, News - Comments

Is Acorda Therapeutics Inc (ACOR) A Good Stock To Buy?

Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter.

Keep Reading →

May 9 - Hedge Funds, News - Comments

Hedge Fund and Insider Trading News: Israel Englander, Omega Advisors, Jabre Capital, Red Lion Hotels Co. (RLH), Amkor Technology, Inc. (AMKR), and More

(Bloomberg) -- It has been yet another year to forget in the world of hedge funds.

Keep Reading →

December 27 - Hedge Funds, Insider Trading - Comments

Hedge Fund and Insider Trading News: David Tepper, Soros Fund Management, Lixte Biotechnology Holdings Inc (LIXT), Acorda Therapeutics Inc (ACOR), Achaogen Inc (AKAO), and More

Hedge fund titan David Tepper said Thursday the Federal Reserve is sending the market a message, and it’s not a good one.

Keep Reading →

December 20 - Hedge Funds, Insider Trading - Comments

Is Acorda Therapeutics Inc (ACOR) A Good Stock To Buy?

The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed...

Keep Reading →

December 14 - Hedge Funds, News - Comments

Hedge Fund and Insider Trading News: John Paulson, Ray Dalio, International Flavors & Fragrances Inc (IFF), KAR Auction Services Inc (KAR), Second Sight Medical Products Inc (EYES), and More

(Reuters) - Activist investor John Paulson’s hedge fund on Thursday said it would urge Detour Gold Corp (DGC.TO) to call a special shareholder meeting to replace a majority ...

Keep Reading →

July 19 - Hedge Funds, Insider Trading - Comments

13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...

Keep Reading →

February 28 - Hedge Funds - Comments

Hedge Fund and Insider Trading News: Och-Ziff Capital Management, Jana Partners, Intrexon Corp (XON), Legacy Reserves LP (LGCY), and More

(Reuters) - Och-Ziff Capital Management on Tuesday named Robert Shafir as its new chief executive officer, succeeding Dan Och after a battle over who will run the hedge fund firm...

Keep Reading →

January 30 - Hedge Funds, Insider Trading - Comments

Hedge Fund and Insider Trading News: Elliot Management, Brevan Howard, Acorda Therapeutics Inc (ACOR), Cognizant Technology Solutions Corp (CTSH), and More

Elliott Management Corp., the hedge fund founded by billionaire Paul Singer, has built a stake in Sky Plc as shareholders prepare to vote on 21st Century Fox Inc.’s 11.7-billion...

Keep Reading →

January 29 - Hedge Funds, Insider Trading - Comments

Market Movers Today: Nike Inc (NKE), Forward Industries, Inc. (FORD), International Business Machines Corp (IBM), and More

Shares of Nike (NYSE:NKE) rose over 3% Friday morning following an upgrade by Wedbush to Outperform (from Neutral) with a new price target of $74.00 (from $57.00).

Keep Reading →

January 19 - Market Movers, News - Comments

13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), Rule 13d...

Keep Reading →

September 11 - Hedge Funds - Comments

13D Filing: Scopia Capital and Acorda Therapeutics Inc (ACOR)

The remainder of this cover page shall be filled out for a reporting persons initial filing on this form with respect to the subject class of securities, and for any subsequent...

Keep Reading →

August 8 - Hedge Funds - Comments

13G Filing: Partner Fund Management and Acorda Therapeutics Inc (ACOR)

You can access the original SEC filing by clicking here.

Keep Reading →

July 10 - Hedge Funds - Comments

Here’s What Is Happening In Financial Markets Today?

“Wall Street stocks on Monday were aiming to start the second quarter with tepid gains.

Keep Reading →

April 3 - Commodities, Gold, Market Movers, News, Tech - Comments

What Is Going On In The Financial Markets Today?

“U.S.

Keep Reading →

March 31 - Commodities, Gold, Market Movers, News, Tech - Comments

Generic Competitors A Looming Threat For Acorda Therapeutics Inc (ACOR)

In order to ensure an extension of Ampyra’s protection to 2026, Acorda Therapeutics Inc (NASDAQ:ACOR) must fight off competition from competitors such as Roxane, Teva Pharmaceutical...

Keep Reading →

February 16 - News, Stock Analysis - Comments

Can Acorda Therapeutics Inc (ACOR) Give Eli Lilly And Co (LLY) A Run For Its Money In Migraine Drug Market?

Acorda Therapeutics Inc (NASDAQ:ACOR) inhaled migraine candidate CVT-427 is seen by Janney analyst Ken Trbovich as likely to give Eli Lilly and Co (NYSE:LLY) severe competition...

Keep Reading →

January 24 - News, Stock Analysis - Comments

Acorda Therapeutics Inc (ACOR) Continues To Fall From Favor With Top Investors

Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to...

Keep Reading →

November 28 - Hedge Funds, News - Comments

Biotech Movers And Shakers: Mast Therapeutics, Inc. (MSTX) And Acorda Therapeutics Inc (ACOR)

To find a winner in the biotech space this week, all you’d need to do is throw a dart at a basket of micro-caps.

Keep Reading →

November 22 - Market Movers, News, Stock Analysis - Comments

Skypeople Fruit Juice Inc. (SPU), Lands’ End Inc. (LE) & Others: Why These Losers Are Dragging Down the Market

The markets continue to trade down in anticipation of the upcoming OPEC meeting.

Keep Reading →

September 26 - Market Movers, News - Comments

Why Does The Smart Money Like Acorda Therapeutics?

Acorda Therapeutics Inc (NASDAQ:ACOR) is a $1.11 billion biotechnology company that develops and commercializes novel therapies for neurological disorders.

Keep Reading →

August 31 - News, Stock Analysis - Comments

Two Big Parkinson’s Updates From Adamas Pharmaceuticals Inc (ADMS) And Acorda Therapeutics Inc (ACOR)

We just got a couple of updates in the Parkinson’s space, and both have the potential to serve up some volatility in the market capitalisations of the companies in question.

Keep Reading →

August 5 - News, Stock Analysis - Comments

Should You Buy Acorda Therapeutics Inc (ACOR)?

Investing in hedge funds can bring large profits, but it’s not for everybody, since hedge funds are available only for high-net-worth individuals.

Keep Reading →

November 30 - Hedge Funds, News - Comments

These Oil and Biotech Stocks Are in the Crosshairs of Elite Investors

While many hedge funds are still preparing their third quarter filings with the SEC, providing the main ingredients for our delectable small-cap investment strategy, some managers...

Keep Reading →

November 2 - Commodities, Hedge Funds, News - Comments

Kyle Bass’ War Against Pharmaceutical Companies Goes On While The Masses Overlook China’s Real Problem

Those who seek to profit from shorting strategies should keep a close eye on Kyle Bass’ war against the pharmaceutical industry.

Keep Reading →

September 17 - Hedge Funds, Macroeconomic Predictions, News - Comments

Acorda Therapeutics Inc (ACOR)’s Shares Jump After Dismissal Of Patent Challenge From Hedge Fund Manager Kyle Bass

The shares of Acorda Therapeutics Inc (NASDAQ:ACOR) are trading 13.16% higher today after the dismissal of a patent challenge against the company.

Keep Reading →

August 25 - Hedge Funds, Market Movers, News - Comments

Nektar Therapeutics (NKTR): Insiders Aren’t Crazy About It But Hedge Funds Love It

Now, according to many of your peers, hedge funds are assumed to be useless, outdated investment vehicles of a forgotten age.

Keep Reading →

September 17 - News - Comments

Acorda Therapeutics Inc (ACOR): Insiders Aren’t Crazy About It But Hedge Funds Love It

To many investors, hedge funds are assumed to be bloated, outdated investment tools of a forgotten age.

Keep Reading →

September 11 - News - Comments

Hedge Funds Are Selling Sarepta Therapeutics Inc (SRPT)

If you were to ask many of your fellow readers, hedge funds are seen as overrated, old investment vehicles of a period lost to current times.

Keep Reading →

August 30 - News - Comments

Alnylam Pharmaceuticals, Inc. (ALNY): Insiders Aren’t Crazy About It But Hedge Funds Love It

If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.

Keep Reading →

August 22 - News - Comments

Alnylam Pharmaceuticals, Inc. (ALNY): Here’s What The Smart Money Thinks

Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.

Keep Reading →

August 6 - News - Comments

Is Nektar Therapeutics (NKTR) Going to Burn These Hedge Funds?

Nektar Therapeutics (NASDAQ:NKTR) was in 8 hedge funds' portfolio at the end of March.

Keep Reading →

June 12 - News - Comments

Is Acorda Therapeutics Inc (ACOR) Going to Burn These Hedge Funds?

Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of March. ACOR has experienced a decrease in hedge fund sentiment lately.

Keep Reading →

June 8 - News - Comments

This Metric Says You Are Smart to Buy Sarepta Therapeutics Inc (SRPT)

Sarepta Therapeutics Inc (NASDAQ:SRPT) was in 19 hedge funds' portfolio at the end of March.

Keep Reading →

June 3 - News - Comments

Idenix Pharmaceuticals Inc (IDIX), Alnylam Pharmaceuticals, Inc. (ALNY) & 3 Small Biotechs Top Hedge Funds Are Investing In

Small biotech companies have great investment potential if you can identify them properly.

Keep Reading →

April 24 - News - Comments

Vertex Pharmaceuticals Incorporated (VRTX), Gilead Sciences, Inc. (GILD): The Week, Biotech – Part Two

As I mentioned previously in Part 1, it was an incredibly busy week for the biotech sector.

Keep Reading →

April 20 - News - Comments

Biogen Idec Inc. (BIIB): What Goes up Must Come Down

Biogen Idec Inc.

Keep Reading →

April 17 - News - Comments

Biopharma News: Theravance Inc (THRX), VIVUS, Inc. (VVUS), Amgen, Inc. (AMGN)

Editor's Note: Related tickers: Theravance Inc (NASDAQ:THRX), VIVUS, Inc. (NASDAQ:VVUS), Amgen, Inc.

Keep Reading →

April 15 - News - Comments

Acorda Therapeutics Inc (ACOR): Insiders Are Dumping, Should You?

Acorda Therapeutics Inc (NASDAQ:ACOR) was in 10 hedge funds' portfolio at the end of the fourth quarter of 2012.

Keep Reading →

April 12 - News - Comments

Insider Monkey HF Resource Center
  • Subscribe to Hedge Fund Alpha
  • How to Beat the Market by 20 Percentage Points
  • Why Track Hedge Funds?
  • Download a Free Edition!
  • Why You Should DUMP Your Hedge Funds
Top Hedge Funds
Warren Buffett

Warren Buffett

Berkshire Hathaway

$293,447,417,000

David Einhorn

David Einhorn

Greenlight Capital

$1,491,303,000

George Soros

George Soros

Soros Fund Management

$5,416,602,000

Jim Simons

Jim Simons

Renaissance Technologies

$77,426,184,000

Leon Cooperman

Leon Cooperman

Omega Advisors

$1,886,381,000

Carl Icahn

Carl Icahn

Icahn Capital LP

$22,521,664,000

Steve Cohen

Steve Cohen

Point72 Asset Management

$22,767,998,000

John Paulson

John Paulson

Paulson & Co

$3,510,256,000

David Tepper

David Tepper

Appaloosa Management LP

$4,198,712,000

Paul Tudor Jones

Paul Tudor Jones

Tudor Investment Corp

$6,160,740,000

Insider Monkey Small Cap Strategy
JulJanJulJanJulJanJulJan0%50%100%150%Return %Monthly Newsletter StrategyS&P 500
Lists

20 Least Populated States in America

20 Least Populated States in America

5 Least Populated States in America

5 Least Populated States in America

12 Biggest Industrial Software Companies in the World

12 Biggest Industrial Software Companies in the World

21 Best Dating Apps of 2023 (ready for review)

21 Best Dating Apps of 2023 (ready for review)

15 Largest Steel Producing Countries in the World

15 Largest Steel Producing Countries in the World

The 30 Most Famous Yale Students Of All Time

The 30 Most Famous Yale Students Of All Time

20 Most Valuable Swedish Companies In The World

20 Most Valuable Swedish Companies In The World

Top 25 Smartest Companies To Buy According To Hedge Funds

Top 25 Smartest Companies To Buy According To Hedge Funds

15 Most Valuable Retail Companies In The World

15 Most Valuable Retail Companies In The World

15 Largest Ophthalmology Companies in the World

15 Largest Ophthalmology Companies in the World

19 Biggest Outdoor Brands and Companies

19 Biggest Outdoor Brands and Companies

15 Countries That Produce The Most Hydropower

15 Countries That Produce The Most Hydropower

15 Biggest Neuroscience Companies in the World

15 Biggest Neuroscience Companies in the World

15 Countries With The Largest Refining Capacity

15 Countries With The Largest Refining Capacity

Top 20 Financial Cities in the World

Top 20 Financial Cities in the World

Top 5 Financial Cities in the World

Top 5 Financial Cities in the World

25 Least Developed Countries in Europe

25 Least Developed Countries in Europe

15 Cheapest New Cars For 2023

15 Cheapest New Cars For 2023

25 Companies That Make the Most Money in the World

5 Companies That Make the Most Money in the World

15 Largest Australian Companies by Revenue

15 Largest Australian Companies by Revenue

5 Largest Australian Companies by Revenue

5 Largest Australian Companies by Revenue

25 Largest British Companies by Revenue

25 Largest British Companies by Revenue

Top 20 Oil Importing Countries in 2023

Top 20 Oil Importing Countries in 2023

21 Largest Italian Companies by Market Cap

21 Largest Italian Companies by Market Cap

17 Most Valuable E-Commerce Companies in the World

17 Most Valuable E-Commerce Companies in the World

Top 20 Oil Exporting Countries in 2023

Top 20 Oil Exporting Countries in 2023

Top 5 Oil Exporting Countries in 2023

Top 5 Oil Exporting Countries in 2023

16 Largest Indian Banks by Assets

16 Largest Indian Banks by Assets

5 Largest Indian Banks by Assets

5 Largest Indian Banks by Assets

25 Most Powerful Countries in Europe

25 Most Powerful Countries in Europe

10 Most Powerful Countries in Europe

10 Most Powerful Countries in Europe

11 Largest Property Management Companies in the US

11 Largest Property Management Companies in the US

30 of the World's Most Valuable Private Companies

30 of the World's Most Valuable Private Companies

25 Largest Privately Held Companies in America

25 Largest Privately Held Companies in America

13 Biggest Eyewear Companies in the World

13 Biggest Eyewear Companies in the World

15 Biggest Natural Gas Pipeline Companies in the World

15 Biggest Natural Gas Pipeline Companies in the World

10 Biggest HVAC Companies in the USA

10 Biggest HVAC Companies in the USA

25 Strongest Countries in Europe by Military Power

25 Strongest Countries in Europe by Military Power

13 Biggest Gold Mines in the World

13 Biggest Gold Mines in the World

10 Most Advanced Battery Technologies That Will Power the Future

10 Most Advanced Battery Technologies That Will Power the Future

22 Largest Hunting Companies in the US

22 Largest Hunting Companies in the US

18 Countries That Produce the Most Nuclear Energy

18 Countries That Produce the Most Nuclear Energy

5 Countries That Produce the Most Nuclear Energy

5 Countries That Produce the Most Nuclear Energy

12 Biggest Cloud Providers by Market Share in the World

12 Biggest Cloud Providers by Market Share in the World

5 Biggest Cloud Providers by Market Share in the World

5 Biggest Cloud Providers by Market Share in the World

25 Wealthiest Countries in the World by GDP Per Capita

25 Wealthiest Countries in the World by GDP Per Capita

25 Biggest New Jersey Companies and Stocks

25 Biggest New Jersey Companies and Stocks

25 Biggest Colorado Companies and Stocks

25 Biggest Colorado Companies and Stocks

9 Famous Pyramid Scheme Companies in US History

9 Famous Pyramid Scheme Companies in US History
Read Me
  • 10 Strategies Hedge Funds Use To Make Huge Returns
  • 5 Best Poker Books For Beginners
  • 15 Highest Grossing Movies Opening Weekend
  • Top 10 Genetically Modified Food In the US
  • 10 Best Places To Visit In Canada
  • Best Summer Jobs For Teachers
  • Top 10 Fast Food Franchises To Buy
  • 10 Youngest Hedge Fund Billionaires
  • Top 10 One Hit Wonders of The 90s
  • Fastest Growing Cities In America
  • 10 Places To Visit Before You Die
  • Best Places To Visit In The USA
  • 10 Most Powerful Countries In The World
  • 25 Best Star Wars Video Games Of All Time
  • Top 10 Richest Cities In The World
  • 10 Most Expensive Homes In The World
  • Best Summer Jobs For College Students
  • 20 Best TED Talks Of All Time
  • 8 Most Corrupt Countries In The World
  • 10 Most Expensive Cities In The World
  • 6 Longest Prison Sentences Ever Given
  • 10 Most Profitable Franchises in 2014
  • 10 Best Warren Buffett Quotes On Life, Investing
  • 10 Most Profitable Small Businesses
  • Top 10 Paid Apps For iPhone 5
Blogroll
  • Acting Man
  • Crackerjack Finance
  • Dividend Monk
  • Farmer's TSX Dividend Listing
  • Pension Pulse

Get our editor’s daily picks straight in your inbox!

RSS Feed Hedge Funds Insider Trading About Us Authors Contact Us Sitemap
Privacy Policy Terms of Use CCPA - Do Not Sell My Information. ©2022 Koala Guide LLC.